NeoChord Announces Positive 1-year Follow-Up Data with Transcatheter NeXuS System for Mitral Chordal Repair Using Multiple Chords to a Single Anchor
October 19, 2022 08:00 ET
|
NeoChord, Inc.
ST. LOUIS PARK, Minn., Oct. 19, 2022 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company, is leading the advancement of beating heart mitral valve repair in...
NeoChord Appoints Martin B. Leon, M.D. as Executive Chair of the U.S. Early Feasibility Study of the NeoChord Transcatheter NeXuS System
March 14, 2022 09:15 ET
|
NeoChord, Inc.
ST. LOUIS PARK, Minn., March 14, 2022 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients...
NeoChord Announces Positive 30-day Results with Transcatheter NeXuS System for Mitral Chordal Repair Using Multiple Chords to a Single Anchor
November 22, 2021 08:00 ET
|
NeoChord, Inc.
ST. LOUIS PARK, Minn., Nov. 22, 2021 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients...
NeoChord Announces Successful Completion of First in Human Procedure with its NeoChord NeXuS Transcatheter Mitral Chordal Repair Technology
October 04, 2021 16:30 ET
|
NeoChord, Inc.
ST. LOUIS PARK, Minn., Oct. 04, 2021 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients...
NeoChord Raises Additional Financing to Drive Catheter-based Program Development, Bringing Total Series D Funding to over $32 Million
April 23, 2019 16:03 ET
|
NeoChord, Inc.
ST. LOUIS PARK, Minn., April 23, 2019 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients...
NeoChord Announces $25 Million Series D Financing to Accelerate Development of Two Transcatheter Chordal Repair Programs
November 05, 2018 08:30 ET
|
NeoChord, Inc.
ST. LOUIS PARK, Minn., Nov. 05, 2018 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients...
NeoChord Announces Successful Completion of First Beating Heart Repair Procedures in China
September 04, 2018 08:03 ET
|
NeoChord, Inc.
ST. LOUIS PARK, Minn., Sept. 04, 2018 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients...
NeoChord宣佈成功完成中國首例不停跳心臟修復手術
September 03, 2018 10:36 ET
|
NeoChord, Inc.
美國明尼蘇達州聖路易斯派克, Sept. 03, 2018 (GLOBE NEWSWIRE) -- 訊：一直引領針對二尖瓣逆流患者的不停跳心臟二尖瓣修復手術進步的NeoChord, Inc.今日宣佈，這家私人控股醫療技術公司在香港的瑪麗醫院成功使用NeoChord手術療程治療了第一批患者，在亞洲這仍屬首例。 ...
NeoChord宣布成功完成中国首例不停跳心脏修复手术
September 03, 2018 10:36 ET
|
NeoChord, Inc.
美国明尼苏达州圣路易斯帕克, Sept. 03, 2018 (GLOBE NEWSWIRE) -- 讯：在针对二尖瓣逆流患者的不停跳心脏二尖瓣修复术方面引领进步的私人控股医疗技术公司NeoChord, Inc.今日宣布，在香港的玛丽医院成功使用NeoChord手术治疗了一位患者，这在在亚洲尚属首例。 ...
NeoChord Announces Successful Completion of First Beating Heart Repair Procedures in China
September 03, 2018 10:36 ET
|
NeoChord, Inc.
ST. LOUIS PARK, Minn., Sept. 03, 2018 (GLOBE NEWSWIRE) -- NeoChord, Inc., a privately-held medical technology company leading the advancement of beating heart mitral valve repair in patients...